MUFG Securities Americas’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Buy
41,036
+1,099
+3% +$87.9K 0.17% 112
2025
Q4
$3.81M Sell
39,937
-20
-0.1% -$1.96K 0.24% 81
2025
Q3
$3.9M Buy
39,957
+7,168
+22% +$742K 0.25% 78
2025
Q2
$3.52M Buy
32,789
+6,701
+26% +$678K 0.3% 59
2025
Q1
$2.63M Buy
26,088
+4,332
+20% +$436K 0.31% 63
2024
Q4
$1.94M Buy
+21,756
New +$1.92M 0.25% 80

Other funds holding BSX

MUFG Securities Americas's BSX Position: Q1 2026 in Review

MUFG Securities Americas increased its Boston Scientific (BSX) stake by 2.8% in Q1 2026, buying an estimated $87.9K and bringing the position to 41,036 shares worth $2.58M. The position accounts for 0.17% of the portfolio, ranked #112.

MUFG Securities Americas first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.9M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • MUFG Securities Americas held 41,036 shares of Boston Scientific worth $2.58M as of Q1 2026.
  • MUFG Securities Americas bought 1,099 Boston Scientific shares in Q1 2026, an estimated $87.9K.
  • Boston Scientific made up 0.17% of MUFG Securities Americas's portfolio in Q1 2026, its #112 holding.
  • MUFG Securities Americas first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's Boston Scientific position peaked at $3.9M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.